INS and Hyperglycemia: For future studies we would use a dose of 25 mg/kg STZ in combination with high-fat feeding, as this induced adiposity, hypercholesterolemia, mild hyperglycaemia without compromising insulin secretion, and exhibited cardiac metabolic changes that mirrored the well characterised shift from glucose to fatty acid metabolism in type 2 diabetes.